CKW Financial Group boosted its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 116.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,200 shares of the company’s stock after purchasing an additional 2,800 shares during the period. CKW Financial Group’s holdings in Avantor were worth $110,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of AVTR. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares during the period. UMB Bank n.a. purchased a new position in shares of Avantor during the 3rd quarter worth approximately $49,000. Nisa Investment Advisors LLC grew its holdings in shares of Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares during the period. GAMMA Investing LLC grew its holdings in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Avantor by 278.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after acquiring an additional 3,700 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Barclays reduced their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Raymond James cut their price target on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st. Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, UBS Group restated a “neutral” rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, Avantor presently has an average rating of “Moderate Buy” and a consensus price target of $27.38.
Avantor Stock Performance
AVTR stock opened at $22.07 on Monday. The stock has a market capitalization of $15.02 billion, a PE ratio of 47.97, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. Avantor, Inc. has a 12-month low of $19.59 and a 12-month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock’s 50 day simple moving average is $21.50 and its 200 day simple moving average is $23.43.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What Is WallStreetBets and What Stocks Are They Targeting?
- A Pivotal Moment for the Consumer Discretionary Sector
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How Mixed Analyst Opinions Are Shaping Apple Stock’s Outlook
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Rezolve Could Be the Next Big Name in Artificial Intelligence
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.